The diagnosis of nontuberculous mycobacterial (NTM) lung disease can be difficult to make in cystic fibrosis (CF) patients, who have chronic pulmonary infections and underlying lung disease. Current diagnosis and treatment guidelines for NTM pulmonary disease are based on data from non-CF patients. The authors review both the CF and non-CF literature and offer recommendations specific to this population.